Principles of anticancer drug development / edited by Manuel Hidalgo ... [et al.].
Material type: TextSeries: Cancer drug discovery and developmentPublication details: New York : Springer, c2011.Description: xvii, 673 p. : ill. (some col.) 25 cmISBN:- 9781441973573 (alk. paper)
- 1441973575 (alk. paper)
- 9781441973580 (eISBN)
- 1441973583 (eISBN)
- RC 271 .C5 P74 2011
Item type | Current library | Call number | Status | Notes | Date due | Barcode | |
---|---|---|---|---|---|---|---|
General circulation | Main Campus Library General Stacks | RC 271 .C5 P74 2011 (Browse shelf(Opens below)) | Available | A.K. | 2016/017794 |
Browsing Main Campus Library shelves, Shelving location: General Stacks Close shelf browser (Hides shelf browser)
RC 271 .C5 C32 2006 Cancer chemotherapy and biotherapy : | RC 271.C5 C32 2006 Cancer drug resistance / | RC 271.C5 P4 2009 Pharmaceutical perspectives of cancer therapeutics / | RC 271 .C5 P74 2011 Principles of anticancer drug development / | RC 271.C5 V4 Handbook of skin care in cancer patients | RC 271.C5 W5 Consumers guide to cancer drugs / | RC 271 .C5 W5 2003 Consumers guide to cancer drugs |
Includes bibliographical references and index.
Basic biostatistics for the clinical trialist / Elizabeth G. Hill and Elizabeth Garrett-Mayer -- Fundamental concepts in clinical pharmacology / Daniel L. Gustafson and Erica L. Bradshaw-Pierce -- Bioanalycial methods in clinical drug development / Walter J. Loos, Peter de Bruijn and Alex Sparreboom -- Preclinical models for anticancer drug development / Edward A. Sausville -- Phase I clinical trials with anticancer agents / Stephen Leong ... [et al.] -- Phase II trials with anticancer agents / Hui K. Gan, J. Jack Lee and Lillian L. Siu -- Phase III clinical trials with anticancer agents / Wendy R. Parulekar and Daniel J. Sargent -- Pharmacokinetic studies in early anticancer drug development / Alex Sparreboom and Sharyn D. Baker -- Pharmacodynamic studies in early phase drug development / D. Ross Camidge, Robert C. Doebele and Antonio Jimeno -- Prediction of antitumor response / Fred R. Hirsch and Yu Shyr -- Imaging studies in anticancer drug development / David A. Mankoff -- Role of the U.S. Food and drug administration in cancer drug development / Ann T. Farrell, Ramzi N. Dagher and Richard Pazdur -- Early clinical trials with cytotoxic agents / M.J.A. de Jonge and Jaap Verweij -- Challenges and successes in developing effective anti-angiogenic agents / Laura Q.M. Chow and S. Gail Eckhardt -- Targeted therapeutics in cancer treatment / Colin D. Weekes and Manuel Hidalgo -- Cancer chemoprevention / Christopher H. Lieu, William N. William Jr. and Scott Lippman -- Combined modality therapy in cancer management / David Raben and Kyle Rusthoven -- Cancer vaccines / Daniel Laheru -- Optimising the development of antibodies as treatment for cancer / Craig P. Carden, Hendrik-Tobias Arkenau and Johann S. de Bono -- Oligonucleotide therapeutics / Cy A. Stein, Britta Hoehn and John Rossi -- Anticancer drug development in pediatric patients / Lia Gore and Margaret Macy -- Clinical trials in special populations / S. Percy Ivy ... [et al.] -- NCI-sponsored clinical trials / Andriana Papaconstantinou and Janet E. Dancey.
There are no comments on this title.